Correction: Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities
Reproductive Health volume 20, Article number: 160 (2023)
Correction: Reproductive Health (2023) 20:58 https://doi.org/10.1186/s12978-023-01574-3
After publication of this article , the authors reported that the Acknowledgements section should have read ‘The authors acknowledge the role of Sarah Jones at VSHD/OASIS for conducting the country assessments and compiling the report findings with the help of in-country consultants, Eugène Kanyamanza, Evangeline Dushimeyesu, Gabriele von Wahlert, Philip Dorrell, and Sameena Chowdhury and as well as the collaboration of key informants who shared their valuable knowledge with the authors.'
The original article  has been corrected.
Grossman A, Prata N, Williams N, Ganatra B, Lavelanet A, Läser L, Asmani C, Elamin H, Ouedraogo L, Rahman MM, Conneh-Duworko MJ, Tehoungue BZ, Chanza H, Phiri H, Bhattarai B, Dhakal NP, Ojo OA, Afolabi K, Kabuteni TJ, Hailu BG, Moses F, Dlamini-Nqeketo S, Zulu T, Rehnström Loi U. Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities. Reprod Health. 2023;20(Suppl 1):58. https://doi.org/10.1186/s12978-023-01574-3.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Grossman, A., Prata, N., Williams, N. et al. Correction: Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities. Reprod Health 20, 160 (2023). https://doi.org/10.1186/s12978-023-01691-z